生物分解性支架市場：依產品類型、依材料類型、依最終用戶、按地區

Biodegradable Stents Market, By Product Type, By Material Type, By End User, By Geography

出版日期: 2025年03月03日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球生物分解性支架市場規模估計為 4.728 億美元，預計到 2032 年將達到 7.793 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.4%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.728億美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的複合年成長率	7.40%	2032年價值預測	7.793億美元

數字。 2025年各地區生物分解性支架市場佔有率（%）

生物分解性支架市場在更廣泛的醫療設備產業中發展迅速。生物分解性支架，又稱生物可吸收支架，用於治療冠狀動脈疾病和周邊動脈疾病。這些支架旨在打通阻塞的動脈，並在一段時間內逐漸溶解在體內，從而無需永久性金屬植入，並降低了與傳統支架相關的併發症的風險。全球生物分解性支架市場受到多種因素的推動，例如心血管疾病盛行率上升、技術進步以及對微創手術的偏好日益增加。市場也受到對傳統支架更好、更安全的替代品日益成長的需求的影響，因為傳統支架會導致血栓症和血管再阻塞等長期併發症。此外，人們越來越意識到生物分解性支架的好處，例如其恢復動脈自然運動和功能的能力，也促進了市場的成長。然而，這些支架的高成本和嚴格的監管核准程序可能會在一定程度上阻礙市場成長。儘管存在這些挑戰，生物分解性支架市場仍具有巨大的成長潛力，並為現有和參與企業提供了無數機會。該市場競爭激烈，主要參與企業專注於研發活動，以推出創新產品並獲得競爭優勢。生物分解性支架市場前景光明，因為它們在醫療領域的應用越來越廣泛，人們越來越認知到它們相對於傳統支架的優勢。

市場動態

全球生物分解性支架市場的主要促進因素是人們對微創治療的偏好日益成長、全球易患心臟病的老齡人口不斷增加以及冠狀動脈疾病和周邊動脈疾病患病率不斷上升。此外，優惠的報銷政策和監管部門的核准正在推動生物分解性支架的採用。然而，與傳統金屬支架相比，生物分解性支架的成本更高，且缺乏長期性能數據是影響市場成長的主要因素。

研究的主要特點

本報告對全球生物分解性支架市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，介紹了全球生物分解性支架市場的主要企業概況。
研究中介紹的主要企業包括波士頓科學公司、雅培、京都醫療規劃有限公司、QualiMed、Elixir Medical Corporation、ENDOCOR GmbH、BIOTRONIK SE & Co.KG、Amaranth Medical, Inc. 和 Arterial Remodeling Technologies SA。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球生物分解性支架市場報告針對該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過全球生物分解性支架市場分析中使用的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 472.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	USD 779.3 Mn

The biodegradable stents market is rapidly evolving within the broader medical devices industry. Biodegradable stents, also known as bioresorbable or bioabsorbable stents, are used in the treatment of coronary artery diseases or peripheral artery diseases. These stents are designed to open up blocked arteries and gradually dissolve in the body over a period of time, eliminating the need for a permanent metallic implant and reducing the risk of complications associated with traditional stents. The global biodegradable stents market is driven by several factors including the rising prevalence of cardiovascular diseases, advancements in technology, and the growing preference for minimally invasive procedures. The market is also influenced by the increasing demand for better and safer alternatives to traditional stents, which can cause long-term complications such as thrombosis and restenosis. Furthermore, growing awareness about the benefits of biodegradable stents, such as their ability to restore the natural movement and function of the artery, is also contributing to the growth of the market. However, the high cost of these stents and the stringent regulatory approval process may hinder the market growth to some extent. Despite these challenges, the biodegradable stents market holds immense potential for growth, with numerous opportunities for existing players and new entrants. The market is characterized by intense competition, with key players focusing on research and development activities to introduce innovative products and gain a competitive edge. The future of the biodegradable stents market looks promising, with increasing adoption in the healthcare sector and growing recognition of their benefits over traditional stents.

Market Dynamics:

The global biodegradable stents market is primarily driven by the growing preference for minimally invasive procedures, rising geriatric population worldwide prone to cardiac ailments, and increasing incidence of coronary and peripheral artery diseases. Additionally, favorable reimbursement policies and regulatory approvals are promoting the adoption of biodegradable stents. However, the high cost of biodegradable stents compared to conventional metallic stents and lack of long-term performance data are the major factors negatively impacting the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global biodegradable stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biodegradable stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., Arterial Remodeling Technologies SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global biodegradable stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodegradable stents market

Detailed Segmentation:

Global Biodegradable Stents Market Segmentation, By Product Type:
- Coronary Stents
- Peripheral Stents
Global Biodegradable Stents Market Segmentation, By Material Type:
- Polymer-based Stents
- Metallic Stents
Global Biodegradable Stents Market Segmentation, By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Global Biodegradable Stents Market Segmentation, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Boston Scientific Corporation
- Abbott
- Kyoto Medical Planning Co., Ltd.
- QualiMed
- Elixir Medical Corporation
- ENDOCOR GmbH
- BIOTRONIK SE & Co. KG
- Amaranth Medical, Inc.
- Arterial Remodeling Technologies SA.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Biodegradable Stents, By Product Type
- Market Biodegradable Stents, By Material Type
- Market Biodegradable Stents, By End User
- Market Biodegradable Stents, By Geography/Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Growing adoption of minimally invasive procedures
- Restraints
High cost of biodegradable stents
- Opportunities
Technological advancements
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Biodegradable Stents Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Biodegradable Stents Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Coronary Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Peripheral Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Biodegradable Stents Market, By Material Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Polymer-based Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Metallic Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Biodegradable Stents Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Biodegradable Stents Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Kyoto Medical Planning Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
QualiMed
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Elixir Medical Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ENDOCOR GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BIOTRONIK SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Amaranth Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Arterial Remodeling Technologies SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views